These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3897966)

  • 41. [Is Streptococcus pneumoniae and Haemophilus influenzae resistance reversible?].
    Aubry-Damon H
    Rev Pneumol Clin; 2000 Oct; Suppl 1():1S21-3. PubMed ID: 11103986
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmacokinetic and clinical studies with meropenem in the pediatric field. Pediatric Study Group of Meropenem].
    Fujii R; Yoshioka H; Fujita K; Maruyama S; Sakata H; Inyaku F; Chiba S; Tsutsumi H; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1992 Jun; 45(6):697-717. PubMed ID: 1507401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Respiratory infections: clinical evaluation.
    Grassi C
    Clin Ther; 1985; 7 Suppl A():45-54. PubMed ID: 3907845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consensus: management of presumed bacterial pneumonia in ambulatory children.
    Grossman M; Klein JO; McCarthy PL; Schwartz RH; McCracken GH; Nelson JD
    Pediatr Infect Dis; 1984; 3(6):497-500. PubMed ID: 6334843
    [No Abstract]   [Full Text] [Related]  

  • 47. [Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections].
    Suzuki K
    Jpn J Antibiot; 2001 May; 54 Suppl B():97. PubMed ID: 12638155
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy of injectable carbapenems for respiratory infections caused by Streptococcus pneumoniae and Haemophilus influenzae with Monte Carlo simulation].
    Mikamo H; Tanaka K; Watanabe K
    Jpn J Antibiot; 2007 Feb; 60(1):47-57. PubMed ID: 17436862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upper airway carriage by Haemophilus influenzae and Streptococcus pneumoniae in Australian aboriginal children hospitalised with acute lower respiratory infection.
    Gratten M; Manning K; Dixon J; Morey F; Torzillo P; Hanna J; Erlich J; Asche V; Riley I
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):123-31. PubMed ID: 7825002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antibacterial activities of piperacillin in several fresh clinical isolates].
    Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Kaku M
    Jpn J Antibiot; 2000 Aug; 53(8):573-81. PubMed ID: 11070819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative evaluation of the in vitro and in vivo antibacterial activity of ceftriaxone and piperacillin: determination of the inhibitory quotient in bronchial secretions].
    Fraschini F; Scaglione F; Ripamonti L; Cogo R; Casali W
    Recenti Prog Med; 1988 May; 79(5):224-9. PubMed ID: 3051198
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of chest infections.
    Hickey BP
    Aust Fam Physician; 1977 Aug; 6(8):983-9. PubMed ID: 303513
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic activity of Oriprim in bronchopulmonary diseases].
    Zamotaev IP; Sokolova VI; Makarenkova RV
    Ter Arkh; 1986; 58(4):128-30. PubMed ID: 3520928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tissue concentrations of piperacillin in humans].
    Bergogne-Berezin E
    Presse Med; 1986 Dec; 15(46):2324-7. PubMed ID: 2949277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Cannesson M; Xuereb F; Rimmelé T; Chassard D; Saux MC; Allaouchiche B
    Intensive Care Med; 2004 May; 30(5):976-9. PubMed ID: 15057512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pneumonia caused by Haemophilus influenzae. Study in a series of 58 patients].
    Sánchez F; Mensa J; Martínez JA; Angrill J; Marcos MA; Marco F; Coll-Vinent B; Torres A; Soriano E
    Rev Esp Quimioter; 1999 Dec; 12(4):369-74. PubMed ID: 10855018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacokinetic and clinical studies of cefuzonam in pediatrics].
    Iwai N; Miyazu M; Shibata M; Nakamura H; Katayama M; Taneda Y; Inokuma K
    Jpn J Antibiot; 1987 Mar; 40(3):641-57. PubMed ID: 3613084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.